Sociology
Racial and Ethnic Representation in Scientific Research Participation
Quick fact
Until the 1990s, many clinical trials deliberately excluded women and people of color, assuming results from white men would apply to everyone. This led to drugs being pulled from the market when they proved dangerous for others.
Why this is interesting
Most medical research has been conducted almost entirely on white men—so can we trust that the drugs and treatments work equally well for everyone?
Read the full explanation
Understanding Racial and Ethnic Representation in Scientific Research Participation
Think of scientific research as a poll: you ask a small sample of people to represent a much larger population. If the sample doesn't mirror the actual diversity of that population, the results are skewed. In research, participation means which people enroll in studies, from small lab experiments to large clinical trials. Historically, participation has been skewed toward white, male, and higher-income groups. This happened for many reasons: scientists often recruited from university communities, some groups distrusted research due to past abuses, and systemic barriers made it harder for marginalized communities to enroll. The result is that we know a lot about how medicines work for one subset of the population—often not the one that needs it most.
A deeper explanation
The mechanism linking underrepresentation to biased science is selection bias. If a study's participants aren't representative, its findings might not apply to those who weren't included. This isn't just a statistical nuance—it has life-or-death consequences. For example, some asthma medications are less effective in African Americans, and certain heart drugs have different responses across ethnic groups. Beyond biology, there are social and historical reasons for underrepresentation: the infamous Tuskegee syphilis study left a legacy of distrust among Black Americans, and policies that required including women and minorities were only introduced in the 1990s (e.g., NIH Revitalization Act). But inclusion alone isn't enough—we need active recruitment, culturally competent communication, and fair benefits to build trust. This matters because science aims to describe and improve the world for all people, and that's impossible if research leaves entire groups out.